Healthcare Business

Biotech & Medical Venture Deals Roundup

From BioHealth Investor

by Adam Rubenstein

NeoVista, Inc. (Fremont, CA), an ophthalmic device company focused on the treatment of age-related macular degeneration, has raised $41M in Series C funding. Essex Woodlands Health Ventures led the deal along with MPM Capital and previous investors SV Life Sciences, Versant Ventures, The Carlyle Group and Accuitive Medical Ventures.

Quinnova Pharmaceuticals, Inc., a specialty dermatological reformulation pharmaceutical company focused on innovative dermal drug delivery platforms, has completed a $13.6M Series A round of financing. Participating in the round are Thomas, McNerney & Partners, H.I.G. Ventures and an investor syndicate led by Omnivest (Bermuda) Ltd.

Ampla Pharmaceuticals, Inc. (La Jolla, CA) has raised $5.47M in Series A funding. Still operating in stealth mode the company website is currently unavailable. Investors include Integra Ventures, Advent International and Crabtree Ventures

Aushon BioSystems (Burlington, MA), which provides microarray-based tools, instrumentation and services for life science research, drug discovery/development and clinical diagnostics, announced they have closed their Series A $7.78M financing. North Bridge Venture Partners led the deal.

Sponsored: Find a Qualified Financial Advisor

Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.